+

WO1999038519A1 - Composition anticancereuse - Google Patents

Composition anticancereuse Download PDF

Info

Publication number
WO1999038519A1
WO1999038519A1 PCT/MK1998/000001 MK9800001W WO9938519A1 WO 1999038519 A1 WO1999038519 A1 WO 1999038519A1 MK 9800001 W MK9800001 W MK 9800001W WO 9938519 A1 WO9938519 A1 WO 9938519A1
Authority
WO
WIPO (PCT)
Prior art keywords
sep
international
republic
preparation
pct
Prior art date
Application number
PCT/MK1998/000001
Other languages
English (en)
Inventor
Ivan Gorgiev
Original Assignee
Ivan Gorgiev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ivan Gorgiev filed Critical Ivan Gorgiev
Priority to AU17857/99A priority Critical patent/AU1785799A/en
Publication of WO1999038519A1 publication Critical patent/WO1999038519A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea

Definitions

  • the anticancer supresiv preparation has been marked by that which contains from extract, a drink and a crystal gruel.
  • the anticancer supresiv preparation depending on request l has been marked by that the extract contains from imula 10-20 mg, aloe cactus 5-10 mg, propolis 1-5 mg and placenta 5-10 mg
  • the extract by request 2 has been marked with that by adding redisti-llate water it treates at a temperature of 30-40 °C, it mixes from 4 to 6 hours and after 8 hours it drips.
  • the anticancer supresiv preparation by request l has been marked that the drink contains from imelo 30-60 mg, imula 20-30 mg,dren 10-20 mg neven 5-10 mg, brigand's grass 2-5 mg, troskot 20-30 mg, kantarion 10-20 mg, cactus 30-40 mg and devil's water 50-100 ml.
  • the drink by request 4 has been marked that by adding redistillate water it treates at a temperature from 30-40 °C,mixes from 4 to 6 hours) and after 8 hours it drips.
  • the anticancer supresiv preparation by request l has been marked that the crystal gruel can be obtained by secreting animal matters,adding of placenta.polysaharides 5-10 mg,linehin 2-5 mg,izolihenin 5-8 mg, protolihesterins acid 2-4 mg,paralihesterina acid 2-5 mg,fumara acid 2-5 mg, useins acid 3-5 mg,minerals Ca(10-50 mg) and Mg(5-25 mg) carbonates 2-5 mg, phosphates 2-5 mg,alcaloids 3-5 mg, protopin 2-4 mg, vitamins A 10-25 mg, E 10-25 mg C 5-10 mg, devil's water 10-20 ml.
  • the crystal gruel by the request 6 has been marked that by adding redestillate water it treates at a temperature from 20-30°C,it mixes from 4 to 6 hours.and after 8 hours it grips and after that it freezes at a temperature of -10°C.
  • PCT/M 98/00001 (81) Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GD,
  • Priority Data SK, SL, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU, ZW,
  • MK European patent (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE).
  • the anticancer supressive preparation with this proposed procedure is a pharmaceutical preparation which helps in solving the problem of spreading the cancer tissues and metastases.
  • This preparation we use components from animal origin which are treated at certain temperature by proper mixing and dripping.

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Insects & Arthropods (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Reproductive Health (AREA)
  • Animal Husbandry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Cette invention se rapporte à une préparation de suppression du cancer, avec son procédé d'utilisation, qui est constituée par une préparation pharmaceutique contribuant à résoudre le problème de la diffusion des tissus cancéreux et des métastases. Pour obtenir cette préparation, on utilise des composants d'origine animale qui sont traités à une certaine température par mélange et instillation appropriés.
PCT/MK1998/000001 1998-01-30 1998-12-18 Composition anticancereuse WO1999038519A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU17857/99A AU1785799A (en) 1998-01-30 1998-12-18 Anticancer composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MK598 1998-01-30
MK980005 1998-01-30

Publications (1)

Publication Number Publication Date
WO1999038519A1 true WO1999038519A1 (fr) 1999-08-05

Family

ID=19740096

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/MK1998/000001 WO1999038519A1 (fr) 1998-01-30 1998-12-18 Composition anticancereuse

Country Status (2)

Country Link
AU (1) AU1785799A (fr)
WO (1) WO1999038519A1 (fr)

Citations (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1130112B (de) * 1960-09-09 1962-05-24 Ciba Geigy Verfahren zur Gewinnung eines Arzneimittels
JPS5473111A (en) * 1977-11-25 1979-06-12 Ikuo Suzuki Acrotine b
EP0002452A1 (fr) * 1977-11-21 1979-06-27 Aloace Co., Ltd. Glycoprotéine isolée d'aloès
JPS55153720A (en) * 1979-05-18 1980-11-29 Lion Corp Production of substance with antiulcerative activity
JPS5913727A (ja) * 1982-07-13 1984-01-24 Lion Corp 抗腫瘍性物質の製造方法
JPS59164725A (ja) * 1983-03-09 1984-09-17 Ajinomoto Co Inc 抗腫瘍活性物質ａｔｆ１０１１、その製造方法およびその用途
JPS6212720A (ja) * 1985-07-10 1987-01-21 Yasahiro Morita アロエ霊芝の製造法
JPS62135429A (ja) * 1985-12-10 1987-06-18 Ryoji Sakai 制癌剤
US4861761A (en) * 1984-06-28 1989-08-29 Dr. Madis Laboratories, Inc. Aloeferon isolation, manufacturing and its applications
JPH01290666A (ja) * 1988-05-17 1989-11-22 Mitsubishi Kasei Corp ベンゾフラン誘導体
JPH01290627A (ja) * 1988-05-17 1989-11-22 Mitsubishi Kasei Corp 抗腫瘍剤
JPH0232025A (ja) * 1988-07-20 1990-02-01 Tsumura & Co 制癌補助剤
JPH0269165A (ja) * 1988-09-02 1990-03-08 Mitsugi Ohashi 癌抑制食品
US4970212A (en) * 1982-05-18 1990-11-13 Nowicky Wassili Method of treating human illnesses which compromise the ability to mount an effective immunological response
JPH04120024A (ja) * 1990-09-07 1992-04-21 Ebisu Tomochika ガン除防飲み物
EP0532156A1 (fr) * 1991-08-29 1993-03-17 Tetsuya Matsuno Diterpenoique à activité physiologique
JPH06197734A (ja) * 1992-12-28 1994-07-19 Api Kk プロポリス組成物及びその製造方法
WO1994028883A1 (fr) * 1993-06-08 1994-12-22 Brown Raymond K Compositions therapeutiques et procedes d'utilisation
JPH07223965A (ja) * 1994-02-08 1995-08-22 Mitsugi Ohashi 抗制癌方法
JPH07298833A (ja) * 1994-05-10 1995-11-14 Hayashibara Biochem Lab Inc プロポリスエキスを含有する発酵物とその製造方法並びに用途
US5468737A (en) * 1982-05-07 1995-11-21 Carrington Laboratories, Inc. Wound healing accelerated by systemic administration of polysaccharide from aloe
JPH07330596A (ja) * 1994-06-01 1995-12-19 Eiken Chem Co Ltd 抗腫瘍剤
JPH08143462A (ja) * 1994-11-18 1996-06-04 San Crest:Kk 免疫賦活剤及び抗腫瘍剤
WO1997011967A1 (fr) * 1995-09-27 1997-04-03 Thomas David Extrait de viscum album (gui)
JPH09117264A (ja) * 1996-08-26 1997-05-06 Api Kk プロポリス組成物及びその製造方法

Patent Citations (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1130112B (de) * 1960-09-09 1962-05-24 Ciba Geigy Verfahren zur Gewinnung eines Arzneimittels
EP0002452A1 (fr) * 1977-11-21 1979-06-27 Aloace Co., Ltd. Glycoprotéine isolée d'aloès
JPS5473111A (en) * 1977-11-25 1979-06-12 Ikuo Suzuki Acrotine b
JPS55153720A (en) * 1979-05-18 1980-11-29 Lion Corp Production of substance with antiulcerative activity
US5468737A (en) * 1982-05-07 1995-11-21 Carrington Laboratories, Inc. Wound healing accelerated by systemic administration of polysaccharide from aloe
US4970212A (en) * 1982-05-18 1990-11-13 Nowicky Wassili Method of treating human illnesses which compromise the ability to mount an effective immunological response
JPS5913727A (ja) * 1982-07-13 1984-01-24 Lion Corp 抗腫瘍性物質の製造方法
JPS59164725A (ja) * 1983-03-09 1984-09-17 Ajinomoto Co Inc 抗腫瘍活性物質ａｔｆ１０１１、その製造方法およびその用途
US4861761A (en) * 1984-06-28 1989-08-29 Dr. Madis Laboratories, Inc. Aloeferon isolation, manufacturing and its applications
JPS6212720A (ja) * 1985-07-10 1987-01-21 Yasahiro Morita アロエ霊芝の製造法
JPS62135429A (ja) * 1985-12-10 1987-06-18 Ryoji Sakai 制癌剤
JPH01290627A (ja) * 1988-05-17 1989-11-22 Mitsubishi Kasei Corp 抗腫瘍剤
JPH01290666A (ja) * 1988-05-17 1989-11-22 Mitsubishi Kasei Corp ベンゾフラン誘導体
JPH0232025A (ja) * 1988-07-20 1990-02-01 Tsumura & Co 制癌補助剤
JPH0269165A (ja) * 1988-09-02 1990-03-08 Mitsugi Ohashi 癌抑制食品
JPH04120024A (ja) * 1990-09-07 1992-04-21 Ebisu Tomochika ガン除防飲み物
EP0532156A1 (fr) * 1991-08-29 1993-03-17 Tetsuya Matsuno Diterpenoique à activité physiologique
JPH06197734A (ja) * 1992-12-28 1994-07-19 Api Kk プロポリス組成物及びその製造方法
WO1994028883A1 (fr) * 1993-06-08 1994-12-22 Brown Raymond K Compositions therapeutiques et procedes d'utilisation
JPH07223965A (ja) * 1994-02-08 1995-08-22 Mitsugi Ohashi 抗制癌方法
JPH07298833A (ja) * 1994-05-10 1995-11-14 Hayashibara Biochem Lab Inc プロポリスエキスを含有する発酵物とその製造方法並びに用途
JPH07330596A (ja) * 1994-06-01 1995-12-19 Eiken Chem Co Ltd 抗腫瘍剤
JPH08143462A (ja) * 1994-11-18 1996-06-04 San Crest:Kk 免疫賦活剤及び抗腫瘍剤
WO1997011967A1 (fr) * 1995-09-27 1997-04-03 Thomas David Extrait de viscum album (gui)
JPH09117264A (ja) * 1996-08-26 1997-05-06 Api Kk プロポリス組成物及びその製造方法

Non-Patent Citations (17)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 7929, Derwent World Patents Index; Class B04, AN 79-53703B, XP002097078 *
DATABASE WPI Section Ch Week 8106, Derwent World Patents Index; Class B04, AN 81-08491D, XP002097074 *
DATABASE WPI Section Ch Week 8409, Derwent World Patents Index; Class B04, AN 84-053808, XP002097075 *
DATABASE WPI Section Ch Week 8443, Derwent World Patents Index; Class B04, AN 84-267372, XP002097076 *
DATABASE WPI Section Ch Week 8709, Derwent World Patents Index; Class B04, AN 87-059541, XP002097077 *
DATABASE WPI Section Ch Week 8730, Derwent World Patents Index; Class B04, AN 87-209282, XP002097070 *
DATABASE WPI Section Ch Week 9002, Derwent World Patents Index; Class B02, AN 90-011029, XP002097071 *
DATABASE WPI Section Ch Week 9002, Derwent World Patents Index; Class B02, AN 90-011052, XP002097072 *
DATABASE WPI Section Ch Week 9011, Derwent World Patents Index; Class B04, AN 90-079186, XP002097073 *
DATABASE WPI Section Ch Week 9016, Derwent World Patents Index; Class B04, AN 90-119494, XP002097063 *
DATABASE WPI Section Ch Week 9222, Derwent World Patents Index; Class B02, AN 92-180856, XP002097068 *
DATABASE WPI Section Ch Week 9433, Derwent World Patents Index; Class B04, AN 94-268663, XP002097067 *
DATABASE WPI Section Ch Week 9542, Derwent World Patents Index; Class D13, AN 95-325486, XP002097069 *
DATABASE WPI Section Ch Week 9603, Derwent World Patents Index; Class B04, AN 96-026382, XP002097066 *
DATABASE WPI Section Ch Week 9608, Derwent World Patents Index; Class B05, AN 96-074751, XP002097065 *
DATABASE WPI Section Ch Week 9632, Derwent World Patents Index; Class B04, AN 96-318851, XP002097064 *
DATABASE WPI Section Ch Week 9728, Derwent World Patents Index; Class B04, AN 97-305499, XP002097062 *

Also Published As

Publication number Publication date
AU1785799A (en) 1999-08-16

Similar Documents

Publication Publication Date Title
WO1999045910A3 (fr) Methodes et compositions pour le traitement et la prevention des mucosites
WO1998010771A8 (fr) Prevention du cancer de l'ovaire par administration de produits a la progestine
WO1997025042A8 (fr) Utilisation d'un agoniste de ppar-alpha et de ppar-gamma dans le traitement du syndrome x
WO1998023046A8 (fr) Procede et appareil de notification a marge elevee
WO1998015622A8 (fr) Transformation et regeneration de cotonniers fertiles
WO1997020575A8 (fr) Vecteurs adenoviraux cibles
WO1998018888A8 (fr) Raffinage d'une huile comestible riche en carotenes naturels et en vitamine e
WO1997048032A8 (fr) Corps cellulaire de metallisation programmable et procede de fabrication
WO1998010386A8 (fr) Dispositif en forme de disque avec materiau de systeme electronique de surveillance d'articles
WO1998000479A8 (fr) Procede d'hydroconversion de raffinat
WO1998022094A3 (fr) Procede de preparation de compositions polyol façonnees ou non façonnees
WO1999015684A8 (fr) Methode
WO1997017980A8 (fr) Traitement de la cardiomyopathie par elimination des auto-anticorps
WO1998016077A8 (fr) Systeme de communication utilisant des donnees de position geographique
WO1998016421A8 (fr) Dispositif de lecture, detection, choix d'objectifs, communication et reponse base sur un aeronef
WO1997047554A8 (fr) Plateau telescopique pour recevoir des charges
WO1998025264A8 (fr) Micro-actionneur de curseur de bord avant
WO1998009686A8 (fr) Melanges d'hydrobromocarbures destines a la protection contre les incendies et les explosions
WO1998015272A8 (fr) Procede d'inhibition de proteines kinases activees par contrainte
WO1998040762B1 (fr) Systeme telemetrique actif guide par image
WO1998023962A8 (fr) Diagnostic de maladies a prions
WO1996001622A8 (fr) Nouvelle preparation pharmaceutique a administration orale contenant un sel magnesien d'omeprazole
WO1997013154A8 (fr) Jauge a enroulements en orientation croisee et a anneau de flux actif
WO1998023002A8 (fr) Baie comportant un cadre inferieur et un cadre superieur constitues d'un profile continu
WO1994024204A3 (fr) Composition de materiau de revetement pour balle de golf

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase

Ref country code: KR

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载